Morgan Stanley Knock-Out HSBA/ DE000MG1PH83 /
11/06/2024 09:21:22 | Var.-0.07 | Denaro13:24:29 | Lettera13:24:29 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.83EUR | -2.41% | 2.68 Quantità in denaro: 45,000 |
2.69 Quantità in lettera: 45,000 |
HSBC Holdings PLC OR... | 4.5129 GBP | 31/12/2078 | Call |
GlobeNewswire
13:31
HUM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Human...
GlobeNewswire
13:30
Sonder Holdings Inc. Announces Amendment to Financing Agreement and Provides Update on Portfolio Opt...
GlobeNewswire
13:30
Agrify Corporation Announces $500K Turnkey Extraction Equipment Deal with Grotech Farms LLC in Bridg...
GlobeNewswire
13:18
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Clas...
GlobeNewswire
13:15
AppTech Payments Announces Strategic Partnership with FISB Solutions to Upgrade Legacy Banking Syste...
GlobeNewswire
13:05
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
GlobeNewswire
13:05
Banks are making climate commitments, but are they actually making a difference?
GlobeNewswire
13:03
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectiv...
GlobeNewswire
13:00
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil
GlobeNewswire
13:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...
GlobeNewswire
13:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2...
GlobeNewswire
13:00
Republic enhances tokenized asset accessibility with Zero Hash's fiat and USDC payment rails
GlobeNewswire
13:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule ...